DUBLIN, Dec 8, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Gastrointestinal Stents Market 2016-2020" report to their offering.
The report forecasts the global gastrointestinal stents market to grow at a CAGR of 3.89% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global gastrointestinal stents market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various gastrointestinal stents, which are segmented as follows:
- Biliary and pancreatic stents.
- Esophageal stents.
- Duodenal stents.
- Colonic stents.
The advances in materials, design, and technology for stents have enabled the introduction of specially designed stents, which are used for specific conditions. The recent materials used in the development of non-vascular stents such as gastrointestinal stents are poly lactic acid-glycolic acid, polycaprolactone, and poly acryl amine. These biodegradable materials have advantages such as the elimination of stent removal and biocompatibility. The use of self-expandable metal stents for treating perforations and anastomotic leaks seems to be promising for SEMSs, which began their evolution with plastic. These may soon evolve into biodegradable stents.
According to the report, gerontology diseases disproportionately affect the aging population, with prominent gastrointestinal disorders such as diverticulosis, bowel diseases, gastrointestinal malignancies, and urinary and fecal related problems. The changes in lifestyle like the increase in unhealthy diet and physical inactivity will result in raised blood pressure, blood glucose, lipids, and obesity. In the past few years, there has been a rise in morbidity and mortality from chronic diseases such as esophageal cancer, colorectal cancer, rectal cancer, and gastrointestinal related critical disorders.
Further, the report states that the gastrointestinal devices are classified as class III devices and are subjected to high risk, and regulatory authorities have enforced a stringent regulatory framework and labeling requirement for medical devices. Medical devices are always considered high risk and undergo safety examination to demonstrate medical efficacy before they are granted approval.
Key vendors:
- BD
- Boston Scientific
- ELLA-CS
- Cook Medical
- Medtronic
- TaeWoong Medical
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Gastrointestinal stents: An overview
Part 06: Market landscape
Part 07: Market segmentation by product
Part 08: Market segmentation by end-user
Part 09: Geographical segmentation
Part 10: Key leading countries
Part 11: Market drivers
Part 12: Impact of drivers
Part 13: Market challenges
Part 14: Impact of drivers and challenges
Part 15: Market trends
Part 16: Buying criteria
Part 17: Vendor landscape
Part 18: Key vendor analysis
Part 19: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/ck9vvt/global
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article